We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Consumer Portfolio Services
CPSS
$201M
| $59K | ﹤0.01% |
+14,000
| New | +$60K |
2016 Q1
0 quarters
|
|
552
Genworth Financial
GNW
$3.38B
| $55K | ﹤0.01% |
+20,000
| New | +$50.6K |
2016 Q1
0 quarters
|
|
553
Axogen
AXGN
$2.09B
| $54K | ﹤0.01% |
+10,000
| New | +$50.8K |
2016 Q1
0 quarters
|
|
|
ECT
554
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $44K | ﹤0.01% |
30,000
| – | – |
2014 Q3
6 quarters
|
|
|
AKS
555
DELISTED
AK Steel Holding Corp
AKS
| $41K | ﹤0.01% |
+10,000
| New | +$28.7K |
2016 Q1
0 quarters
|
|
|
PLM
556
DELISTED
PolyMet Mining Corp.
PLM
| $41K | ﹤0.01% |
4,910
-1,000
| -17% | -$8.32K |
2013 Q2
11 quarters
|
|
|
VNRBP
557
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
| $37K | ﹤0.01% |
12,240
-2,150
| -15% | -$9.77K |
2014 Q1
8 quarters
|
|
|
BLPH
558
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $31K | ﹤0.01% |
+833
| New | +$30.9K |
2016 Q1
0 quarters
|
|
|
ARNA
559
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $20K | ﹤0.01% |
1,000
| – | – |
2015 Q3
2 quarters
|
|
560
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $16K | ﹤0.01% |
111
| – | – |
2015 Q2
3 quarters
|
|
|
EXXI
561
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $16K | ﹤0.01% |
25,566
| – | – |
2014 Q4
5 quarters
|
|
562
Denison Mines
DNN
$2.14B
| $14K | ﹤0.01% |
25,000
| – | – |
2013 Q2
11 quarters
|
|
563
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $14K | ﹤0.01% |
+3,750
| New | +$9.81K |
2016 Q1
0 quarters
|
|
|
GPIC
564
DELISTED
Gaming Partners International Corporation
GPIC
| $14K | ﹤0.01% |
1,328,275
| – | – |
2013 Q2
11 quarters
|
|
565
DELISTED
BKF CAPITAL GROUP,INC
BKF
| $12K | ﹤0.01% |
17,000
| – | – |
2013 Q2
11 quarters
|
|
|
TLOG
566
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $9K | ﹤0.01% |
+52,471
| New | +$14.6K |
2016 Q1
0 quarters
|
|
|
QMM
567
DELISTED
QUATERRA RESOURCES INC LTD
QMM
| $6K | ﹤0.01% |
136,175
| – | – |
2013 Q2
11 quarters
|
|
|
GMO
568
DELISTED
General Moly, Inc.
GMO
| $5K | ﹤0.01% |
13,518
| – | – |
2013 Q2
11 quarters
|
|
569
Atossa Therapeutics
ATOS
$26.4M
| $3K | ﹤0.01% |
4
| – | – |
2015 Q2
3 quarters
|
|
570
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
| $1K | ﹤0.01% |
30,600
| – | – |
2014 Q3
6 quarters
|
|
571
AerCap
AER
$22.9B
| – | – |
-57,348
| Closed | -$2.48M | – |
|
572
American Express
AXP
$212B
| – | – |
-2,915
| Closed | -$203K | – |
|
573
Biogen
BIIB
$34.8B
| – | – |
-9,365
| Closed | -$2.87M | – |
|
574
B2Gold
BTG
$6.84B
| – | – |
-11,000
| Closed | -$11K | – |
|
575
Celanese
CE
$5.1B
| – | – |
-11,308
| Closed | -$761K | – |
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.